No profile data available.
Aldeyra Therapeutics, Inc. (ALDX) is a healthcare company in the eye treatment pharmaceuticals industry, based in Lexington, United States, with about 6 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$33.85 million. Its market capitalization was $55.28 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
Aldeyra Therapeutics reported $0 in revenue for fiscal year 2025.
$55.28 million as of October 9, 2026.
Listed companies of a similar size in the same industry (eye treatment pharmaceuticals) include Outlook Therapeutics, Inc. (OTLK), Lenz Therapeutics, Inc. (LENZ), Okyo Pharma Limited (OKYO), Hyperion DeFi, Inc. (HYPD).